The MSH3 gene helps repair small mistakes that can happen when cells copy DNA. This gene plays an important role in keeping repeated stretches of DNA stable, so if it does not work properly, extra DNA errors can build up over time. When both copies of the MSH3 gene carry pathogenic variants, some people develop many colon polyps and have a higher chance of colorectal cancer. Changes in this gene are also studied in tumors because they can affect how cancer cells behave.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to build proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they occur, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in LearnHub.
Overview
MSH3Gene function
What if the gene works
The MSH3 gene helps cells find and repair small copying mistakes in DNA, especially extra or missing DNA letters. This supports stable genetic information as cells grow and divide.
Risk
What if the gene does not work
When both copies of the MSH3 gene are not working, DNA repair falls and people can develop multiple colon polyps and colorectal cancer, usually in adulthood. Milder variants may lead to later onset or fewer polyps.
Treatment
What does that mean for your treatment
No MSH3-specific treatment or drug selection approach is currently established in clinical guidelines. The MSH3 gene is being studied in cancer research as part of DNA repair pathways and as a possible biomarker of response to some treatments, but this has not yet led to routine, gene-specific prescribing.
Conditions associated with MSH3
Gene function
What if the gene works
When cells copy their DNA, tiny spelling slips can appear. The MSH3 gene helps notice a specific group of these mistakes, especially extra or missing DNA letters in short stretches. By guiding repair at the right time, it supports stable DNA in many dividing cells.
Inside your cells, the MSH3 gene helps spot small loops that form when DNA is copied. These loops happen when a few DNA letters are accidentally added or skipped.
Its protein usually works alongside the protein from the MSH2 gene. Together they mark the mismatch so other repair proteins can remove the wrong section and replace it.
This is one way the MSH3 gene helps repair DNA copying mistakes in short repeated stretches. When it works properly, those repeat regions stay more stable as cells divide.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences among people, including appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. In some situations, though, a variant can change how a gene works more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MSH3 gene can change the shape, stability, or amount of the MSH3 protein, weakening its partnership with MSH2 and reducing repair of small DNA copying slips, especially extra or missing DNA letters. More severe variants may stop protein production altogether, while milder variants can leave some repair activity. This range helps explain how MSH3 gene variants affect function and why, when both copies are strongly affected, polyposis linked to the MSH3 gene may start earlier or be more extensive.
How variants are linked to conditions
Pathogenic variants in both copies of the MSH3 gene cause a rare inherited condition called MSH3-associated polyposis. People with this condition often develop many bowel polyps in the colon and rectum, and the MSH3 gene and colorectal cancer risk are closely linked in this setting. Some also develop polyps in the duodenum, the first part of the small intestine.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with harmful changes in both copies of the MSH3 gene, the chance of developing many colon polyps and colorectal cancer is mainly driven by the inherited gene change itself. There is not enough evidence to say that specific lifestyle steps lower this gene-related risk, but regular screening can help find and remove polyps early.
Inheritance of MSH3 variants
For families asking about the MSH3 inheritance pattern, the best-established MSH3-related condition follows an autosomal recessive pattern. This means a person usually inherits one changed copy of the MSH3 gene from each parent, and parents who each carry one variant are often unaffected themselves. When both parents are carriers, each pregnancy has a 25% chance of a child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because the MSH3 gene is on chromosome 5, inheritance is the same for males and females.
What does my MSH3 result mean for my family?
For families with an MSH3-related polyposis condition, the pattern is usually recessive, which means close relatives may also carry the gene change even if they have no symptoms. Brothers and sisters could have the same condition or be carriers, and children are usually carriers unless the other parent also carries an MSH3 change. The meaning for relatives depends on whether the result is one changed copy or two changed copies linked to disease.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MSH3 variants uses a blood or saliva sample to read the DNA in the MSH3 gene. A lab checks for changes linked to inherited conditions and reports whether a variant was found, not found, or remains uncertain.
When should I consider getting a genetic test?
Testing for MSH3 can be worth considering if you or close relatives have had many colon polyps or bowel cancer, especially at a younger age. Inherited changes in both copies of this gene can cause a family tendency to form polyps and raise bowel cancer risk.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they reveal depends on the condition and on the kind of variant present. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may break down, move, or respond to a drug in different ways. These differences are common and can influence how well a medicine works or how likely someone is to notice side effects. Age, liver and kidney function, and other medicines can also shape the overall response.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medicines. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medications, genes can affect how strongly a drug works or how the body handles it. This information can support more informed and individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the MSH3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor. MSH3 has been studied in cancer research as one of several genes that help repair damaged DNA and may affect how some tumors respond to certain chemotherapy drugs, but it is not used routinely to guide treatment.
History
In the 1990s, researchers identified the MSH3 gene while tracing the human counterparts of bacterial DNA repair genes, a major step in understanding inherited changes linked to cancer. Early work placed MSH3 within the growing mismatch repair field, alongside other genes that were being connected to Lynch syndrome and related conditions. Building on this early work, scientists uncovered more about the gene through studies of colorectal tumors and laboratory models of repeated DNA sequences. Those studies helped show that MSH3 had a distinct place in the broader repair system rather than simply duplicating the role of similar genes. Over time, interest in the MSH3 gene also grew in research on repeat expansion conditions, adding another chapter to its scientific history.